Pharmacologic Agents Quick Memory (English)
"Weight, Heart, Kidney – Metformin Leads, Others Follow"
Metformin:
"Neutral weight, Neutral heart, Neutral kidney, A Strong Start."
SGLT2 inhibitors (Empa, Cana, Dapa):
"Lose weight, Save the heart and kidney."
GLP-1 receptor agonists (Dula, Lira, Sema):
"Weight loss champions, Protect the heart and kidney."
Tirzepatide (GIP/GLP-1 agonist):
"New and promising, Trials pending."
DPP-4 inhibitors:
"Safe but Saxagliptin risks heart."
Thiazolidinediones (Pioglitazone):
"Weight gain but heart help (pio), Beware heart failure."
Sulfonylureas & Insulin:
"Weight gain, Neutral effects otherwise."
药物速记法（中文）
“体重、心脏、肾脏——二甲双胍领先，其他跟随”
二甲双胍:
“体重中性，心脏中性，肾脏中性，起点强。”
SGLT2 抑制剂（Empa, Cana, Dapa）:
“减重，保护心脏和肾脏。”
GLP-1 受体激动剂（Dula, Lira, Sema）:
“减重冠军，心肾保护者。”
Tirzepatide (GIP/GLP-1 受体激动剂):
“新星，等待试验结果。”
DPP-4 抑制剂:
“安全，但Saxagliptin可能伤心。”
噻唑烷二酮类 (Pioglitazone):
“体重增加但对心脏有益（Pio），小心心衰。”
磺脲类 & 胰岛素:
“增重，其他影响中性。”
Memory Table Summary (English & Chinese)
| Drug | Memory Tip (English) | 记忆法（中文） |
|---|---|---|
| Metformin | Neutral all; strong start. | 体重、心脏、肾脏中性，起点强。 |
| SGLT2 inhibitors | Lose weight; save heart, kidney. | 减重，保护心脏和肾脏。 |
| GLP-1 agonists | Weight loss champions; protect heart, kidney. | 减重冠军，心肾保护者。 |
| Tirzepatide | New and promising; trials pending. | 新星，等待试验结果。 |
| DPP-4 inhibitors | Safe but Saxagliptin risks heart. | 安全，但Saxagliptin可能伤心。 |
| Thiazolidinediones | Weight gain; pioglitazone helps heart; beware heart fail. | 增重，Pioglitazone有益心脏，小心心衰。 |
| Sulfonylureas/Insulin | Weight gain; neutral effects otherwise. | 增重，其他影响中性。 |
By combining these quick mnemonics, you can efficiently recall the effects of key Type 2 diabetes medications.
